Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Genomic profile and immune contexture in colorectal cancer-relevance for prognosis and immunotherapy

S. Meršaková, Z. Lasabová, J. Strnádel, M. Kalman, E. Gabonova, P. Sabaka, R. Ciccocioppo, L. Rodrigo, P. Kruzliak, P. Mikolajčík

. 2021 ; 21 (2) : 195-204. [pub] 20200727

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004382

Grantová podpora
APVV-16-0066 Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR

Colorectal cancer (CRC) is one of the leading cancers in both genders. TNM staging system is still the most commonly used tumor classification and prognostic system. The disadvantage of TNM is that the prognostic information it provides is incomplete, and patients with the same histological tumor stages may differ significantly in the clinical outcome. Therefore, the identification of new prognostic parameters is crucial. The carcinogenic process that gives rise to an individual tumor is unique and tumor microenviroment should be taken into consideration. In CRC, T-cell infiltration is not homogenous, and recent studies are mostly focusing on memory T-cells and CD8 cells in predicting disease-free survival (DFS) and overall survival (OS). It seems that DFS and OS are not only dependent on microsatellite instable or stable status but mostly on the levels of expression of the immune signatures. Also, patients with high infiltration of cytotoxic and memory cells have significantly better outcome. This review consolidates current knowledge and recent research about importance of immune-cell-associated proteins, specific gene profiles of immune cells and immunotherapy in CRC. We also discussed cell-specific signatures in cancer treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004382
003      
CZ-PrNML
005      
20220616091618.0
007      
ta
008      
220113s2021 it f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10238-020-00649-w $2 doi
035    __
$a (PubMed)32720224
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Meršaková, Sandra $u Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
245    10
$a Genomic profile and immune contexture in colorectal cancer-relevance for prognosis and immunotherapy / $c S. Meršaková, Z. Lasabová, J. Strnádel, M. Kalman, E. Gabonova, P. Sabaka, R. Ciccocioppo, L. Rodrigo, P. Kruzliak, P. Mikolajčík
520    9_
$a Colorectal cancer (CRC) is one of the leading cancers in both genders. TNM staging system is still the most commonly used tumor classification and prognostic system. The disadvantage of TNM is that the prognostic information it provides is incomplete, and patients with the same histological tumor stages may differ significantly in the clinical outcome. Therefore, the identification of new prognostic parameters is crucial. The carcinogenic process that gives rise to an individual tumor is unique and tumor microenviroment should be taken into consideration. In CRC, T-cell infiltration is not homogenous, and recent studies are mostly focusing on memory T-cells and CD8 cells in predicting disease-free survival (DFS) and overall survival (OS). It seems that DFS and OS are not only dependent on microsatellite instable or stable status but mostly on the levels of expression of the immune signatures. Also, patients with high infiltration of cytotoxic and memory cells have significantly better outcome. This review consolidates current knowledge and recent research about importance of immune-cell-associated proteins, specific gene profiles of immune cells and immunotherapy in CRC. We also discussed cell-specific signatures in cancer treatment.
650    _2
$a kolorektální nádory $x genetika $x imunologie $x patologie $7 D015179
650    _2
$a výpočetní biologie $7 D019295
650    _2
$a lidé $7 D006801
650    _2
$a inhibitory kontrolních bodů $x terapeutické užití $7 D000082082
650    _2
$a imunoterapie $7 D007167
650    _2
$a staging nádorů $7 D009367
650    _2
$a prognóza $7 D011379
650    _2
$a sekvenční analýza RNA $7 D017423
650    _2
$a nádorové mikroprostředí $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Lasabová, Zora $u Department of Molecular Biology and Genomics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Mala Hora 4, 036 01, Martin, Slovakia. zora.lasabova@uniba.sk
700    1_
$a Strnádel, Ján $u Division of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
700    1_
$a Kalman, Michal $u Department of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, University Hospital, Comenius University in Bratislava, Martin, Slovakia
700    1_
$a Gabonova, Eva $u Clinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin, University Hospital, Comenius University in Bratislava, Martin, Slovakia
700    1_
$a Sabaka, Peter, $u Department of Infectiology and Geographical Medicine, Faculty Medicine, Comenius University and University Hospital, Bratislava, Slovakia $d 1984- $7 xx0129262
700    1_
$a Ciccocioppo, Rachele $u Gastroenterology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata Policlinico GB Rossi, University of Verona, Verona, Italy
700    1_
$a Rodrigo, Luis $u Faculty of Medicine, Central University Hospital of Asturias (HUCA), University of Oviedo, Oviedo, Spain
700    1_
$a Kruzliak, Peter $u Second Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekarska 53, 65691, Brno, Czech Republic. kruzliakpeter@gmail.com
700    1_
$a Mikolajčík, Peter $u Clinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin, University Hospital, Comenius University in Bratislava, Martin, Slovakia
773    0_
$w MED00006222 $t Clinical and experimental medicine $x 1591-9528 $g Roč. 21, č. 2 (2021), s. 195-204
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32720224 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220616091612 $b ABA008
999    __
$a ok $b bmc $g 1751748 $s 1155531
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 21 $c 2 $d 195-204 $e 20200727 $i 1591-9528 $m Clinical and Experimental Medicine $n Clin Exp Med $x MED00006222
GRA    __
$a APVV-16-0066 $p Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...